Comparison of OPTI-FREE RepleniSH and ReNu Multi-Plus Lens Care Regimens on Corneal Epithelium
NCT ID: NCT00724269
Last Updated: 2012-10-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2009-10-31
2011-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
SCREENING
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Opti Free RepliniSH
Opti Free RepliniSH
OPTI-FREE RepleniSH
Multi-Purpose Solution for soft contact lenses
ReNu Multi-Plus
ReNu Multi-Plus
ReNu MultiPlus MPS
Multi-Purpose Solution for soft contact lenses
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
OPTI-FREE RepleniSH
Multi-Purpose Solution for soft contact lenses
ReNu MultiPlus MPS
Multi-Purpose Solution for soft contact lenses
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Wear contact lenses at least 8 hours/day
* Vision correctable to at least 20/30
* Normal Eyes
Exclusion:
* Topical ocular medication use
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alcon Research
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Contact Alcon Call Center for Study Locations
Fort Worth, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SMA-08-04 / BP-08-01
Identifier Type: -
Identifier Source: org_study_id